ARTICLE | Company News
Bio-Matrix Scientific, University of Western Ontario deal
March 4, 2013 8:00 AM UTC
Bio-Matrix's Regen BioPharma Inc. subsidiary signed a letter of intent to acquire IP from the university related to gene silencing technology to treat breast cancer. The IP relates to the administrati...